US Patent 11026974 Restimulation of cryopreserved tumor infiltrating lymphocytes
Patent 11026974 was granted and assigned to Iovance Biotherapeutics, Inc. on June, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11026974 Restimulation of cryopreserved tumor infiltrating lymphocytes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.